Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCR4-NOT transcription complex subunit 6 (CNOT6) is the catalytic component of the CCR4-NOT complex, a highly conserved multi-protein complex involved in global regulation of mRNA stability and gene expression[1][3][5]. CNOT6 encodes a poly(A)-specific ribonuclease with 3′–5′ exonuclease activity, preferentially targeting polyadenylated RNA substrates and driving mRNA deadenylation—a key step in initiating mRNA decay, modulating miRNA-mediated repression, and controlling gene expression during key cellular processes such as proliferation and senescence[1][2][5]. Alongside its structural paralog CNOT6L, CNOT6 is essential for the deadenylase module of the complex but with distinct tissue expression and functional roles[5]. In summary, CNOT6 is an enzymatic factor, not a classical therapeutic target (such as a receptor or transporter), but plays a central regulatory role in post-transcriptional gene regulation[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCR4-NOT transcription complex subunit 6 (CNOT6).